These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 22278967

  • 1. Novel 4-amino bis-pyridinium and bis-quinolinium derivatives as choline kinase inhibitors with antiproliferative activity against the human breast cancer SKBR-3 cell line.
    Gómez-Pérez V, McSorley T, See Too WC, Konrad M, Campos JM.
    ChemMedChem; 2012 Apr; 7(4):663-9. PubMed ID: 22278967
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Symmetrical bis-quinolinium compounds: new human choline kinase inhibitors with antiproliferative activity against the HT-29 cell line.
    Sánchez-Martín R, Campos JM, Conejo-García A, Cruz-López O, Báñez-Coronel M, Rodríguez-González A, Gallo MA, Lacal JC, Espinosa A.
    J Med Chem; 2005 May 05; 48(9):3354-63. PubMed ID: 15857141
    [Abstract] [Full Text] [Related]

  • 5. Bispyridinium cyclophanes: novel templates for human choline kinase inhibitors.
    Conejo-García A, Campos JM, Sánchez-Martín RM, Gallo MA, Espinosa A.
    J Med Chem; 2003 Aug 14; 46(17):3754-7. PubMed ID: 12904080
    [Abstract] [Full Text] [Related]

  • 6. Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors.
    Rubbini G, Buades-Martín AB, Kimatrai-Salvador M, Entrena A, Gallo-Mezo MÁ, Ríos-Marco P, Marco C, Mattiuzzo E, Bortolozzi R, Mariotto E, Greco FA, Macchiarulo A, Carrasco-Jiménez MP, Viola G, López-Cara LC.
    Future Med Chem; 2018 Aug 01; 10(15):1769-1786. PubMed ID: 30043647
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Quantitative structure-activity relationships for a series of symmetrical bisquaternary anticancer compounds.
    Campos JM, Núñez MC, Sánchez RM, Gómez-Vidal JA, Rodríguez-González A, Báñez M, Gallo MA, Lacal JC, Espinosa A.
    Bioorg Med Chem; 2002 Jul 01; 10(7):2215-31. PubMed ID: 11983519
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors.
    Rubio-Ruíz B, Conejo-García A, Ríos-Marco P, Carrasco-Jiménez MP, Segovia J, Marco C, Gallo MA, Espinosa A, Entrena A.
    Eur J Med Chem; 2012 Apr 01; 50():154-62. PubMed ID: 22348828
    [Abstract] [Full Text] [Related]

  • 17. Choline kinase inhibitors as a novel approach for antiproliferative drug design.
    Hernández-Alcoceba R, Saniger L, Campos J, Núñez MC, Khaless F, Gallo MA, Espinosa A, Lacal JC.
    Oncogene; 1997 Nov 06; 15(19):2289-301. PubMed ID: 9393874
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and biological activity of new bispyridinium salts of 4,4'-bispyridyl-5,5'-perfluoroalkyl-2,2'-bisoxazoles.
    Martín-Cantalejo Y, Sáez B, Monterde MI, Murillo MT, Braña MF.
    Eur J Med Chem; 2011 Nov 06; 46(11):5662-7. PubMed ID: 21996467
    [Abstract] [Full Text] [Related]

  • 19. Direct inhibition of choline kinase by a near-infrared fluorescent carbocyanine.
    Arlauckas SP, Popov AV, Delikatny EJ.
    Mol Cancer Ther; 2014 Sep 06; 13(9):2149-58. PubMed ID: 25028471
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.